$7.08
0.273.96%
At Close: -
$7.08
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Viemed Healthcare
VMDNASDAQ
Viemed Healthcare (NASDAQ:VMD) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | VMD | Viemed Healthcare | Q2 | 2024 | — | — | — | $53.80M | $54.80M | $52.50M | Get Alert |
| 03/06/2024 | VMD | Viemed Healthcare | Q1 | 2024 | — | — | — | $49.70M | $51.00M | $51.90M | Get Alert |
| 11/01/2023 | VMD | Viemed Healthcare | Q4 | 2023 | — | — | — | $49.80M | $51.00M | $52.00M | Get Alert |
| 08/09/2023 | VMD | Viemed Healthcare | Q3 | 2023 | — | — | — | $49.00M | $50.20M | $52.00M | Get Alert |
| 05/08/2023 | VMD | Viemed Healthcare | Q2 | 2023 | — | — | — | $40.20M | $41.20M | $38.47M | Get Alert |
| 03/02/2023 | VMD | Viemed Healthcare | Q1 | 2023 | — | — | — | $38.00M | $39.00M | $39.50M | Get Alert |
| 11/01/2022 | VMD | Viemed Healthcare | Q4 | 2022 | — | — | — | $37.10M | $38.10M | $37.10M | Get Alert |
| 08/02/2022 | VMD | Viemed Healthcare | Q3 | 2022 | — | — | — | $34.50M | $35.50M | $34.40M | Get Alert |
| 05/03/2022 | VMD | Viemed Healthcare | Q2 | 2022 | — | — | — | $32.30M | $33.10M | $32.50M | Get Alert |
| 03/07/2022 | VMD | Viemed Healthcare | Q1 | 2022 | — | — | — | $30.60M | $32.00M | — | Get Alert |
| 11/01/2021 | VMD | Viemed Healthcare | Q4 | 2021 | — | — | — | $29.30M | $30.50M | — | Get Alert |
| 08/02/2021 | VMD | Viemed Healthcare | Q3 | 2021 | — | — | — | $27.30M | $28.60M | — | Get Alert |
| 03/03/2021 | VMD | Viemed Healthcare | Q1 | 2021 | — | — | — | $27.80M | $29.80M | — | Get Alert |
| 11/04/2020 | VMD | Viemed Healthcare | Q4 | 2020 | — | — | — | $31.00M | $33.00M | $26.42M | Get Alert |
FAQ
What is the most recent guidance for Viemed Healthcare (VMD)?
There have been no specific sales or earnings guidance reported for Viemed Healthcare in recent months.
Browse guidance and forecast on all stocks.